TGF‐β1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation
- 19 April 2010
- journal article
- Published by Wiley in Cancer Science
- Vol. 101 (5), 1108-1116
- https://doi.org/10.1111/j.1349-7006.2010.01512.x
Abstract
Overexpression of transforming growth factor-beta1 (TGF-beta1) and its downstream molecules in the rhabdomyosarcoma (RMS) RD cell line has been reported previously, but the regulatory role of TGF-beta1 on RMS has not been studied extensively. In the present study, we showed that expression of TGF-beta1 and its downstream molecules type II TGF-beta receptor (TbetaRII) and Smad4 was significantly higher in RMS than in normal skeletal muscle, and there was a significant relationship between TGF-beta1 expression and histological grade. Gene silencing with TGF-beta1 short-hairpin RNA (shRNA)-expressing vectors significantly decreased the growth of RD cells, which was confirmed by caspase-3 (in vitro) and TUNEL (in vivo) assays. Moreover, a proportion of treated rhabdomyosarcoma (RD) cells changed to a round shape from the normal fusiform or polygonal shape and expressed myofilaments. Myogenin is one of the myogenic differentiation genes (MyoD) family of myogenic regulators, and was obviously higher in TGF-beta1-shRNA-treated tumors than it in control at the mRNA and protein level. Immunohistochemical staining with myogenic differentiation markers such as myosin and desmin in subcutaneous RMS tissue showed that TGF-beta1 shRNA increased staining for myosin. These results provide new insight into the biological function of TGF-beta1 in malignant tumors, and imply that the TGF-beta1 signal pathway is a potential therapeutic target for drugs that induce differentiation of RMS.Keywords
This publication has 34 references indexed in Scilit:
- Transforming growth factor‐β signaling in cancer invasion and metastasisInternational Journal of Cancer, 2007
- Genetic Deficiency of p38α Reveals its Critical Role in Myoblast Cell Cycle Exit:The p38α-JNK ConnectionCell Cycle, 2007
- A delicate balance: TGF‐β and the tumor microenvironmentJournal of Cellular Biochemistry, 2007
- Alterations in components of the TGF-β superfamily signaling pathways in human cancerCytokine & Growth Factor Reviews, 2006
- Systematic analysis of the TGF-β/Smad signalling pathway in the rhabdomyosarcoma cell line RDInternational Journal of Experimental Pathology, 2003
- TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3Genes & Development, 2001
- TGF‐β autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cellsThe FASEB Journal, 2000
- Interplay between proliferation and differentiation within the myogenic lineageDevelopmental Biology, 1992
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors.Proceedings of the National Academy of Sciences of the United States of America, 1987